Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies

Human Gene Therapy

Volumn 25, Issue 4, 2014, Pages 375-384

  Carr, David J ^a,b   Wallace, Jacqueline M ^b   Aitken, Raymond P ^b   Milne, John S ^b   Mehta, Vedanta ^a   Martin, John F ^a   Zachary, Ian C ^a   Peebles, Donald M ^a   David, Anna L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; FIBROBLAST GROWTH FACTOR 2; GUANYLATE CYCLASE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BIPARIETAL DISTANCE; BIRTH WEIGHT; BLOOD VESSEL REACTIVITY; BODY COMPOSITION; CONTROLLED STUDY; DIETARY INTAKE; DOPPLER FLOWMETRY; DOSE RESPONSE; EMBRYO TRANSFER; FEMALE; FETAL WELL BEING; FETOPLACENTAL UNIT; FETUS; FETUS GROWTH; FETUS WEIGHT; GENE THERAPY; GESTATIONAL AGE; GROWTH RATE; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; LIVER WEIGHT; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OVINE MODEL; PLACENTA FUNCTION; PLACENTA WEIGHT; PROTEIN EXPRESSION; SPLEEN WEIGHT; UMBILICAL ARTERY; UMBILICAL CORD BLOOD FLOW; UTERINE ARTERY; UTERUS BLOOD FLOW; VASODILATATION; ADENOVIRIDAE; ADMINISTRATION AND DOSAGE; ANGIOGENESIS; ANIMAL; BLOOD FLOW; ECHOGRAPHY; FETAL GROWTH RETARDATION; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; METABOLISM; PLACENTA; PLACENTA CIRCULATION; PREGNANCY; UTERUS;

ADENOVIRIDAE; ANIMALS; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PLACENTAL CIRCULATION; PREGNANCY; REGIONAL BLOOD FLOW; TRANSDUCTION, GENETIC; UTERINE ARTERY; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899128995     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2013.214     Document Type: Article

References (40)

1. Barker, D.J. (2006). Adult consequences of fetal growth restriction. Clin. Obstet. Gynecol. 49, 270-283. (Pubitemid 44317915)
2. Bernstein, I.M., et al. (2000). Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am. J. Obstet. Gynecol. 182, 198-206. (Pubitemid 30074392)
3. Carr, D.J., et al. (2011). Ultrasonographic assessment of growth and estimation of birthweight in late gestation fetal sheep. Ultrasound Med. Biol. 37, 1588-1595.
4. Carr, D.J., et al. (2012). Fetoplacental biometry and umbilical artery Doppler velocimetry in the overnourished adolescent model of fetal growth restriction. Am. J. Obstet. Gynecol. 207, 141.e6-141.e15.
5. Costeloe, K., et al. (2000). The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 106, 659-671.
6. Cox, P., and Marton, T. (2009). Pathological assessment of intrauterine growth restriction. Best Pract. Res. Clin. Obstet. Gynaecol. 23, 751-764.
7. David, A.L., et al. (2008). Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep. Gene. Ther. 15, 1344-1350.
8. Degani, S. (2001). Fetal biometry: clinical, pathological, and technical considerations. Obstet. Gynecol. Surv. 56, 159-167. (Pubitemid 32202568)
9. Figueras, F., et al. (2011). Neurobehavioral outcomes in preterm, growth-restricted infants with and without prenatal advanced signs of brain-sparing. Ultrasound Obstet. Gynecol. 38, 288-294.
10. Figueroa, R., and Maulik, D. (2006). Prenatal therapy for fetal growth restriction. Clin. Obstet. Gynecol. 49, 308-319. (Pubitemid 44317918)
11. Ghidini, A. (1996). Idiopathic fetal growth restriction: a pathophysiologic approach. Obstet. Gynecol. Surv. 51, 376-382. (Pubitemid 26177550)
12. GRIT Study Group. (2003). A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG 110, 27-32.
13. Halliday, H.L. (2009). Neonatal management and long-term sequelae. Best Pract. Res. Clin. Obstet. Gynaecol. 23, 871-880.
14. Holmes, D.I., and Zachary, I. (2005). The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol. 6, 209.
15. Konje, J.C., Howarth, E.S., Kaufmann, P., and Taylor, D.J. (2003). Longitudinal quantification of uterine artery blood volume flow changes during gestation in pregnancies complicated by intrauterine growth restriction. BJOG 110, 301-305. (Pubitemid 36298916)
16. Lang, U., et al. (2003). Uterine blood flow-a determinant of fetal growth. Eur. J. Obstet. Gynecol. Reprod. Biol. 110 Suppl 1, S55-S61. (Pubitemid 37072141)
17. Lea, R.G., et al. (2007). The expression of ovine placental lactogen, StAR and progesterone-associated steroidogenic enzymes in placentae of overnourished growing adolescent ewes. Reproduction 133, 785-796. (Pubitemid 46831903)
18. Mandruzzato, G., et al. (2008). Intrauterine restriction (IUGR). J. Perinat. Med. 36, 277-281.
19. Marlow, N., et al. (2005). Neurologic and developmental disability at six years of age after extremely preterm birth. N. Engl. J. Med. 352, 9-19. (Pubitemid 40075676)
20. Mehta, V., et al. (2011). Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A(165) in the uterine arteries of pregnant sheep. Gene Ther. 19, 925-935.
21. Meschia, G. (1983). Circulation to female reproductive organs. In Handbook of Physiology, Sect. 2, Vol. III, Part 1. J.T. Shepherd and F.M. Abboud, eds. (American Physiological Society, Bethesda, MD) pp 241-269.
22. Miller, S.L., Loose, J.M., Jenkin, G., and Wallace, E.M. (2009). The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus. Am. J. Obstet. Gynecol. 200, 102.e1-102.e7.
23. Morse, S.B., et al. (2006). Racial and gender differences in the viability of extremely low birth weight infants: a populationbased study. Pediatrics 117, e106-e112. (Pubitemid 46050507)
24. Nahum, G.G., and Stanislaw, H. (2003). Ultrasonographic prediction of term birth weight: how accurate is it? Am. J. Obstet. Gynecol. 188, 566-574. (Pubitemid 36250003)
25. Peebles, D.M. (2004). Fetal consequences of chronic substrate deprivation. Semin. Fetal. Neonatal. Med. 9, 379-386.
26. Redmer, D.A., et al. (2005). Influence of maternal nutrition on messenger RNA expression of placental angiogenic factors and their receptors at midgestation in adolescent sheep. Biol. Reprod. 72, 1004-1009. (Pubitemid 40404279)
27. Redmer, D.A., et al. (2009). Fetoplacental growth and vascular development in overnourished adolescent sheep at day 50, 90 and 130 of gestation. Reproduction 137, 749-757.
28. Reynolds, L.P., and Redmer, D.A. (1995). Uteroplacental vascular development and placental function. J. Anim. Sci. 73, 1839-1851.
29. Reynolds,L.P., Ferrell,C.L., Robertson, D.A., and Ford, S.P. (1986). Metabolism of the gravid uterus, fetus and utero-placenta at several stages of gestation in cows. J. Agric. Sci. 106, 437-444.
30. Robinson, J.S., Kingston, E.J., Jones, C.T., and Thorburn, G.D. (1979). Studies on experimental growth retardation in sheep. The effect of removal of a endometrial caruncles on fetal size and metabolism. J. Dev. Physiol. 1, 379-398. (Pubitemid 10064332)
31. Roza, S.J., et al. (2008). What is spared by fetal brain-sparing? Fetal circulatory redistribution and behavioral problems in the general population. Am. J. Epidemiol. 168, 1145-1152.
32. Scherjon, S., Briet, J., Oosting, H., and Kok, J. (2000). The discrepancy between maturation of visual-evoked potentials and cognitive outcome at five years in very preterm infants with and without hemodynamic signs of fetal brain-sparing. Pediatrics 105, 385-391. (Pubitemid 30078682)
33. Wallace, J.M., Da Silva, P., Aitken, R.P., and Cruickshank, M.A. (1997). Maternal endocrine status in relation to pregnancy outcome in rapidly growing adolescent sheep. J. Endocrinol. 155, 359-368. (Pubitemid 27475831)
34. Wallace, J.M., et al. (2000). Relationship between nutritionallymediated placental growth restriction and fetal growth, body composition and endocrine status during late gestation in adolescent sheep. Placenta 21, 100-108. (Pubitemid 30099501)
35. Wallace, J.M., et al. (2002). Blood flows and nutrient uptakes in growth-restricted pregnancies induced by overnourishing adolescent sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R1027-R1036. (Pubitemid 34664554)
36. Wallace, J.M., Aitken, R.P., Milne, J.S., Hay, W.W., Jr. (2004). Nutritionally mediated placental growth restriction in the growing adolescent: consequences for the fetus. Biol. Reprod. 71, 1055-1062. (Pubitemid 39249787)
37. Wallace, J.M., et al. (2006a). Nutritional modulation of adolescent pregnancy outcome-a review. Placenta 27 Suppl A, S61-S68.
38. Wallace, J.M., Milne, J.S., Redmer, D.A., and Aitken, R.P. (2006b). Effect of diet composition on pregnancy outcome in overnourished rapidly growing adolescent sheep. Br. J. Nutr. 96, 1060-1068. (Pubitemid 46470169)
39. Wallace, J.M., Milne, J.S., Matsuzaki, M., and Aitken, R.P. (2008). Serial measurement of uterine blood flow from mid to late gestation in growth restricted pregnancies induced by overnourishing adolescent sheep dams. Placenta 29, 718-724.
40. Zachary, I., Mathur, A., Yla-Herttuala, S., and Martin, J. (2000). Vascular protection: a novel nonangiogenic cardiovascular role for vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 20, 1512-1520. (Pubitemid 30353882)